These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 85302)

  • 21. Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis.
    Huijbers MG; Lipka AF; Plomp JJ; Niks EH; van der Maarel SM; Verschuuren JJ
    J Intern Med; 2014 Jan; 275(1):12-26. PubMed ID: 24215230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle.
    Oda K; Shibasaki H
    Brain Res; 1988 May; 449(1-2):337-40. PubMed ID: 2456129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of the acetylcholine receptor and specificities of antibodies to it in myasthenia gravis.
    Lindstrom JM
    Ciba Found Symp; 1982; (90):178-96. PubMed ID: 6923807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An enzyme-linked immunosorbent assay for antibodies against saline-soluble muscle components in myasthenia gravis.
    Akazawa S; Furukawa S; Kamo I; Furukawa Y; Satoyoshi E; Hayashi K
    J Immunol Methods; 1986 Nov; 94(1-2):161-7. PubMed ID: 3782808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies against nicotinic acetylcholine receptor and skeletal muscle in human and experimental myasthenia gravis.
    Aarli JA; Mattsson C; Heilbronn E
    Scand J Immunol; 1975; 4(8):849-52. PubMed ID: 1215840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)].
    Toyka KV; Becker T; Fateh-Moghadam A; Besinger UA; Brehm G; Neumeier D; Heininger K; Birnberger KL
    Klin Wochenschr; 1979 Sep; 57(18):937-42. PubMed ID: 502359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of foetal and adult human acetylcholine receptors with serum from patients with myasthenia gravis.
    Lotwick H; Harrison R; Lunt G; Behan P
    J Neuroimmunol; 1983 Jun; 4(3):167-74. PubMed ID: 6853696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial autoimmune myasthenia gravis with different pathogenetic antibodies.
    Provenzano C; Arancio O; Evoli A; Rocca B; Bartoccioni E; de Grandis D; Tonali P
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1228-30. PubMed ID: 3225607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies.
    Tzartos SJ; Seybold ME; Lindstrom JM
    Proc Natl Acad Sci U S A; 1982 Jan; 79(1):188-92. PubMed ID: 6948300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1985 Jun; 60(3):631-6. PubMed ID: 2410169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subunit structure and peptide mapping of junctional and extrajunctional acetylcholine receptors from rat muscle.
    Nathanson NM; Hall ZW
    Biochemistry; 1979 Jul; 18(15):3392-401. PubMed ID: 465480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
    Drachman DB; Angus CW; Adams RN; Kao I
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against human neuroblastoma cells in the sera of patients with myasthenia gravis.
    Müller KM; Andersson LC
    J Neuroimmunol; 1984 Dec; 7(2-3):97-105. PubMed ID: 6210305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
    Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
    J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of false negative results in the immunoassay for anti-acetylcholine receptor antibodies in myasthenia gravis.
    Mittag TW; Xu X; Moshoyiannis H; Kornfeld P; Genkins G
    Clin Immunol Immunopathol; 1984 May; 31(2):191-201. PubMed ID: 6713740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
    Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.